MDC-002

N/A

Report date: 2025/04/11 17:57:47
NME

Base Information

Drug NameMDC-002
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/potassium-transporting ATPase stimulantsSolute Carrier Family 8 Member B1 stimulants
TargetsSodium/potassium-transporting ATPaseSolute Carrier Family 8 Member B1
Therapy Area/IndicationsPersian Gulf SyndromeAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisEhlers-Danlos Syndrome +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMitodicure GmbH
China Registration ClassN/A

Develop Information

Active CompaniesMitodicure GmbH
Inactive CompaniesN/A
Active IndicationsPersian Gulf SyndromeAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisEhlers-Danlos Syndrome +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A